Literature DB >> 1420049

Acyclovir in herpes zoster ophthalmicus.

C P Herbort.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1420049      PMCID： PMC505253          DOI： 10.1136/bjo.76.10.639-a

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

Review 1.  Diagnosis and therapy of herpes zoster ophthalmicus.

Authors:  T J Liesegang
Journal:  Ophthalmology       Date:  1991-08       Impact factor: 12.079

2.  [Prevention of ocular complications of herpes zoster ophthalmicus by adequate treatment with acyclovir].

Authors:  F X Borruat; E R Buechi; B Piguet; P Fitting; L Zografos; C P Herbort
Journal:  Klin Monbl Augenheilkd       Date:  1991-05       Impact factor: 0.700

3.  Oral acyclovir in herpes zoster ophthalmicus.

Authors:  S P Harding; S M Porter
Journal:  Curr Eye Res       Date:  1991       Impact factor: 2.424

4.  Double-masked trial of topical acyclovir and steroids in the treatment of herpes zoster ocular inflammation.

Authors:  R J Marsh; M Cooper
Journal:  Br J Ophthalmol       Date:  1991-09       Impact factor: 4.638

5.  Oral acyclovir in the treatment of acute herpes zoster ophthalmicus.

Authors:  L M Cobo; G N Foulks; T Liesegang; J Lass; J E Sutphin; K Wilhelmus; D B Jones; S Chapman; A C Segreti; D H King
Journal:  Ophthalmology       Date:  1986-06       Impact factor: 12.079

6.  Intravenous acyclovir in acute herpes zoster infection.

Authors:  J McGill; D R MacDonald; C Fall; G D McKendrick; A Copplestone
Journal:  J Infect       Date:  1983-03       Impact factor: 6.072
  6 in total
  1 in total

Review 1.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.